Biological membranes and membrane proteins

Biological membranes and membrane proteins represent a broad structural and functional category rather than a single, specific therapeutic target. Biological membranes are complex lipid bilayers that provide essential compartmentalization for cells and organelles, while membrane proteins—including integral, peripheral, and lipid-anchored types—mediate critical processes such as signal transduction, molecular transport, and cell-cell communication (Source: StatPearls). It is estimated that approximately 50-60% of all currently approved clinical drugs target membrane proteins, most notably G protein-coupled receptors (GPCRs), ion channels, and transporters, highlighting their immense pharmacological importance (Source: Nature Reviews Drug Discovery). Dysregulation of membrane protein function or alterations in membrane integrity are central to the pathogenesis of a wide array of human diseases, including oncogenesis, neurological decline, and metabolic syndromes (Source: PubMed). Because this entry encompasses thousands of distinct molecular entities with diverse physiological roles, it is classified as a general biological category rather than an individual actionable target (Source: UniProt). Effective therapeutic intervention requires the identification of specific protein isoforms or membrane components to minimize off-target effects and ensure clinical efficacy (Source: NIH).

Other names

Cell membranePlasma membraneIntegral membrane proteinsPeripheral membrane proteinsTransmembrane proteinsLipid bilayer

Drugs targeting components of biological membranes typically function by binding to specific membrane-bound receptors as agonists or antagonists, inhibiting membrane-embedded enzymes, or modulating the conductance of ion channels and the activity of solute transporters (Source: StatPearls). Some agents may also act by altering the physical properties or permeability of the lipid bilayer itself (Source: PubMed).